An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.
Health Professionals
Site-Specific Melanoma Trends May Be Related to Genetic Risk
WEDNESDAY, July 31, 2024 (HealthDay News) — Site-specific melanoma incidence trends may be partially related to genetic risk, according to a study published online July 19 in the British Journal of Dermatology.
Integrated 15-GEP and PRAME Classifier Shows Prognostic Accuracy in Uveal Melanoma
Integrating 15-GEP with PRAME expression status into a 4-group prognostic classification system showed prognostic accuracy in uveal melanoma.
Study provides novel insights into the molecular mechanisms of melanoma progression
Cong Peng et al., at Department of Dermatology, Xiangya Hospital, Central South University, China, conducted a study titled “NETO2 promotes melanoma progression via activation of the Ca²?/CaMKII signaling pathway" that investigates the role of Neuropilin and tolloid-like 2 (NETO2) in melanoma, a deadly form of skin cancer.